Stay updated on Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe footer revision label has been updated from v3.5.2 to v3.5.3, indicating a site/version release without changing the study details presented on the page.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3. This is a metadata revision and does not affect the study information.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.4.2. Removed the Revision: v3.4.1 notice regarding government funding status.SummaryDifference0.4%

- Check90 days agoChange DetectedAdded a site-wide notice about government funding and operating status, and updated the page revision information to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.